Skip to content

OMDA OMDA Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Teladoc Health logo
Teladoc HealthTDOC
$0-100%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$450K+28.9%
Insulet logo
InsuletPODD
$400K-84.0%
Hinge Health, Inc. logo
Hinge Health, Inc.HNGE
$410K+323%
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$69.99M
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$23.37M+96.1%

Other financials

Income statement

See full
Revenue$78.0M+42.0%
Gross profit$48.7M+52.6%
Operating income-$4.8M+43.1%
Net income-$3.0M+68.6%
EPS (diluted)-$0.05+95.7%

Balance sheet

See full
Cash & equivalents$211.8M+257%
Total debt$30.0M
Total equity$234.1M+160%
Total assets$302.8M

Cash flow

See full
Operating cash flow-$11.8M+26.6%
CapEx$78.0K-75.2%
Free cash flow-$11.9M+27.5%

Valuation

See full
Market cap$1.11B+23.8%
P/S3.9×-0.4×

Profitability

See full
Gross margin66.3%+4.4pp
Operating margin-9.6%-4.0pp
Net margin-11.3%-4.6pp
FCF margin-40.8%

Returns & leverage

See full
Return on equity26.8%
Debt / equity0.1×
Current ratio3.9×

Where this comes from

Reported directly by OMDA in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: OMDA’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about OMDA's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OMDA's stock issuance proceeds?
OMDA (OMDA) reported stock issuance proceeds of $3.25M in Q1 2026.
How has OMDA's stock issuance proceeds changed year-over-year?
OMDA's stock issuance proceeds increased by 253.3% year-over-year, from $919K to $3.25M.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.